Cancer is still one of the leading causes of death worldwide. Nanotechnology, particularly
nanoparticle-based platforms, is at the leading edge of current cancer management …

Doxorubicin (DOX) is one of the most commonly used drugs in liver cancer. Unfortunately,
the traditional chemotherapy with DOX presents many limitations, such as a systematic …

The aim of this study is to design a drug delivery system in which both the carrier material
and the flavonoid anticancer, chemopreventive and chemotherapeutic active substance to …

Abstract Development of advanced drug nanocarriers that can improve cancer
chemotherapeutic efficacy, reduce side effect and drug resistance is of particular interests. In …

This study aims to synthesize a core-shell gelatin-based carbon quantum dot-molecularly
imprinted polymer (MIP@ g-CQD) via the precipitation free-radical polymerization process …

Hyperthermia is considered a promising strategy to boost the curative outcome of traditional
chemotherapeutic treatments. However, this thermally mediated drug delivery is still affected …

Researchers in cancer nanomedicine are exploring a revolutionary multifaceted carrier for
treatment and diagnosis, resulting in the proposal of various drug cargos or “magic bullets” …

Oral cancer, particularly squamous cell carcinoma (SCC), has posed a grave challenge to
global health due to its high incidence, metastasis, and mortality rates. Despite numerous …

Lung cancer ranks as the second most commonly diagnosed cancer in both men and
women worldwide. Despite the availability of diverse diagnostic and treatment strategies, it …

The limited penetration of nanocarriers into tumors and the slow release of drugs from these
carriers to tumor cells are significant challenges in cancer therapy. In this study, we …